GeoVax Labs, Inc. (QB) Stock Price - GOVX

Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Ultimate Trader
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
GeoVax Labs, Inc. (QB) GOVX OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 0.0007 0.00075 0.0006 0.00075 0.0007 15:59:47
Bid Price Ask Price Spread Spread % News
0.0006 0.0008 0.0002 25.0% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
38 10,106,849 $ 0.000689 $ 6,962 22,498,747 0.00059 - 3.75
Last Trade Time Type Quantity Stock Price Currency
15:56:39 50,000 $ 0.0007 USD

GeoVax Labs, Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 298.42k 426.31M $ -2.56M - - 106.31M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
365.78k $ - 0.00% - -

more financials information »

GeoVax Labs, Inc. (QB) News

Loading Messages....

Latest GOVX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GOVX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0010.0010.000590.00075728,045,978-0.0003-30.0%
1 Month0.00130.00230.000590.001324530,272,125-0.0006-46.15%
3 Months0.02330.03590.000590.003008325,207,451-0.0226-97.0%
6 Months1.801.800.000590.003477811,876,018-1.80-99.96%
1 Year0.02753.750.000590.00487426,599,511-0.0268-97.45%
3 Years0.05853.750.000590.01189532,664,228-0.0578-98.8%
5 Years0.2353.750.000590.01483291,656,158-0.2343-99.7%

GeoVax Labs, Inc. (QB) Description

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases using our Modified Vaccinia Ankara - Virus-Like Particle (MVA-VLP) vaccine platform. Our current development programs are focused on preventive vaccines against HIV, Zika virus, Hemorrhagic Fever viruses (Ebola, Sudan, Marburg, Lassa), and malaria, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. Our vaccine platform supports in vivo production of non-infectious VLPs in the person receiving the vaccine. The production of VLPs in the person being vaccinated mimics virus production in a natural infection, stimulating both the humoral and cellular arms of the ijmmune system to recognize, prevent, and control the target infection.

Your Recent History
GeoVax Lab..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.